RxDoctor Payments Data

Eric Osborn

Interventional Cardiology · Boston, MANPI 1548445240

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,994 of the $58,482 with a category attached, or 88.9%. 8 manufacturers reported payments, led by Gentuity, LLC at 47.4% of the total.

$58,482in general payments, 2019–2025

Across 47 payments — averaging $1244.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gentuity, LLC$28K
  • Abbott$19K
  • Opsens Inc.$4K
  • Philips North America LLC$3K
  • Abiomed$3K
  • Cardiva Medical, Inc.$2K
  • plus $126 from 2 others
$185,291in research payments, 2019–2025

Across 37 payments — averaging $5007.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gentuity, LLC$67K
  • Philips North America LLC$60K
  • Abbott$39K
  • Cardiva Medical, Inc.$17K
  • Medtronic$2K

What the payments were for

  • Consulting fees$51,99489%
  • Speaking & faculty fees$5,2009%
  • Travel & lodging$3021%
  • Food & beverage$8982%
  • Entertainment$890%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,482 in reported general payments places this provider in the 80th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$92,530
Medicare patients
380
Services billed
765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →